Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational studyRosa Ruchlemer, Tamar Lachish, Ronen Ben‐Ami et al.|Mycoses|2019Cited by 80
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E.D. Chamuleau, Marie José Kersten, Erik W.A. Marijt et al.|Haematologica|2019Cited by 53
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensLiesbeth E.M. Oosten, Hendrik Veelken, Martine E.D. Chamuleau et al.|Annals of Hematology|2017Cited by 44
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemiaArnon P. Kater, Mark‐David Levin, Marinus H. J. van Oers et al.|Haematologica|2018Cited by 13